Business Corpus: Biotech Stocks To Watch And Pharma Industry NewsTrack the latest trends and leading stocks in the biotech and pharmaceutical industries. The post Biotech Stocks To Watch And Pharma Industry News appeared first on Investor's Business Daily.

[Collection]

One minute Dow Jones industrial average component Merck (MRK) might be doing battle with fellow drugmaker Bristol-Myers Squibb (BMY) over drugs that can ward off cancer.

The next, biotech giants like Amgen (AMGN) and Sanofi (SNY) are tussling in court over the fate of cholesterol-busting drugs. Meanwhile, a company like Gilead Sciences (GILD) might be raked over the coals in Congress for charging $1,000 a day to treat hepatitis.

It's a brave – and contentious – new world for pharmaceutical and biotechnology companies. It's a realm where science is trying to develop landmark medicines that cure cancer, hepatitis and other life-threatening illnesses.

All the while it does a delicate dance with Wall Street and regulators – balancing public health issues with the demands of shareholders. Investors will find it tricky to navigate the sector, as companies can rise and fall at the drop of a hat.

Bookmark this page to stay on top of the latest news in the biopharma sector.

Biotech And Pharma News

Valeant Pops After Topping Quarterly Views And Unveiling Its New NameValeant Pharmaceuticals popped early Tuesday after the drugmaker topped Wall Street's first-quarter sales expectations, raised 2018 guidance and said it will change its name to Bausch Health Companies. In premarket trading on... Read More

Takeda Pharmaceuticals Clinches $62 Billion Acquisition Of ShireTakeda Pharmaceuticals clinched the $62 billion acquisition of Shire after a six-week back-and-forth that also briefly included potential interest from Allergan, it was learned Tuesday. The total deal values Shire at 49.01 pounds,... Read More

IBD Rating Upgrades: Puma Biotechnology Flashes Improved Price StrengthThe Relative Strength (RS) Rating for Puma Biotechnology climbed into a new percentile Tuesday, as it got a lift from 70 to 78. When looking for the best stocks to buy and... Read More

Alder Biopharmaceuticals Shows Improved Relative Price Performance; Still Shy Of BenchmarkAlder Biopharmaceuticals had its Relative Strength (RS) Rating upgraded from 65 to 71 Tuesday -- a welcome improvement, but still short of the 80 or better score you look for. When looking... Read More

Stock Upgrades: Corcept Therapeutics Shows Rising Relative StrengthCorcept Therapeutics saw a welcome improvement to its Relative Strength (RS) Rating on Tuesday, rising from 79 to 88. When looking for the best stocks to buy and watch, one factor to... Read More

Intrexon Clears Key Benchmark, Hitting 80-Plus RS RatingWhen building your watch list, focus on stocks with an 80 or higher RS Rating. Intrexon now meets that criteria, with an increase from 80 to 86 Tuesday. When looking for the... Read More

Fibrogen Hits 80-Plus Relative Strength Rating BenchmarkFibrogen had its Relative Strength (RS) Rating upgraded from 80 to 84 Tuesday. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.IBD's... Read More

View More Biotech And Pharma Stock News

RELATED:

Best Stocks To Buy And Watch

The post Biotech Stocks To Watch And Pharma Industry News appeared first on Investor's Business Daily.